Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · New Jersey

Acrotech Biopharma

East Windsor, NJ · ~53 workers · 2 years of OSHA Injury Tracking Application data.

C
Average Safety Record
0.0
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Acrotech Biopharma runs at 0% of its industry's injury rate - about level with the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade C.

Acrotech Biopharma: 0.0 TCR = 0% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 2y Form 300A (see methodology below)

Acrotech Biopharma safety composite

Acrotech Biopharma scores strongest on total case rate (tcr) (safer than 100% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

82/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
A 0 per 100 workers

Safer than 100% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Acrotech Biopharma held a steady TCR band

Acrotech Biopharma's TCR held near 0.0 from 0.0 in 2022 to 0.0 in 2023. Peak filing year was 2022 at 0.0 TCR.

2022=0.0 · 2023=0.0

OSHA ITA Form 300A scorecard

Establishment book 325412 · East Windsor, NJ AT/BELOW-IND · SMALL

Grade C · TCR 0.0 · 0% of ind

  • DART 0.0 DART
  • RANK #0/93
  • PHOTO Astellas Pharma Glob…
  • BOOK 2y book
  • INJ 0 inj
  • SIZE ~53 FTE

Nearest TCR peer: Astellas Pharma Global Development (0.0 TCR gap)

Read with this employer → · Industry book → · New Jersey employers → · Look up another →

Acrotech Biopharma in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Acrotech Biopharma averages 0.0 TCR (0% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Acrotech Biopharma TCR series: 2022=0 · 2023=0 · BLS 3.3

Where Acrotech Biopharma falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 100% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to New Jersey alone (the establishments it most directly competes with for workers and contracts): ranked #0 safest of 93 Pharmaceutical preparations (e employers in New Jersey.

Acrotech Biopharma (53 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate Acrotech Biopharma
Acrotech Biopharma (53 employees, TCR 0.0) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

Acrotech Biopharma has fewer employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2023 0.0 0.0 0 0 0
2022 0.0 0.0 0 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · NJ · East Windsor

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 11,201 rated employers in New Jersey with headcount on file · 28 employers in East Windsor, NJ · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Astellas Pharma Global Development 0.0 TCR
NAICS-TCR Astellas US LLC 0.1 TCR
NAICS-TCR Mylan Pharmaceutical - Greenbag Road 0.1 TCR
NAICS-TCR Janssen Ortho LLC-Gurabo 0.1 TCR
STATE-SIZE 4039-03601100-00W001 53 FTE
STATE-SIZE J. Servidone Jr. Equipment & Sales 53 FTE
STATE-SIZE J.D'Annunzio & Sons Inc. 53 FTE
STATE-SIZE Franklin Township Public Works 53 FTE
CITY-NEAR Shiseido America Inc. 927 FTE
CITY-NEAR Conair East Windsor New Jersey 417 FTE
CITY-NEAR #506 East Windsor Shoprite 272 FTE
CITY-NEAR Conair Corporation - East Windsor, NJ 257 FTE
NAT-TCR Kinship Pointe Seward 0.0 TCR
NAT-TCR 1655 3rd St,San Francisco (MB3 0.0 TCR
NAT-TCR Chicago Corporate 0.0 TCR
NAT-TCR Lawrenceburg 0.0 TCR
NAT-SIZE Brookdale Englewood 53 FTE
NAT-SIZE Gulf Shores Precast Erectors dba Gulf Coast Precast Erectors 53 FTE
NAT-SIZE AJA Construction Services, Inc. 53 FTE
NAT-SIZE KleenTech Inc 53 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2023, 2022. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.